146 related articles for article (PubMed ID: 1446806)
1. PGE2 prevents anomalies induced by hyperglycemia or diabetic serum in mouse embryos.
Goto MP; Goldman AS; Uhing MR
Diabetes; 1992 Dec; 41(12):1644-50. PubMed ID: 1446806
[TBL] [Abstract][Full Text] [Related]
2. Development of rat embryos in culture media containing different concentrations of normal and diabetic rat serum.
Styrud J; Eriksson UJ
Teratology; 1992 Nov; 46(5):473-83. PubMed ID: 1462252
[TBL] [Abstract][Full Text] [Related]
3. Hyperglycemia-induced teratogenesis is mediated by a functional deficiency of arachidonic acid.
Goldman AS; Baker L; Piddington R; Marx B; Herold R; Egler J
Proc Natl Acad Sci U S A; 1985 Dec; 82(23):8227-31. PubMed ID: 3934670
[TBL] [Abstract][Full Text] [Related]
4. Reduced SOD activity and increased neural tube defects in embryos of the sensitive but not of the resistant Cohen diabetic rats cultured under diabetic conditions.
Weksler-Zangen S; Yaffe P; Ornoy A
Birth Defects Res A Clin Mol Teratol; 2003 Jun; 67(6):429-37. PubMed ID: 12962287
[TBL] [Abstract][Full Text] [Related]
5. Evidence that elevated glucose causes altered gene expression, apoptosis, and neural tube defects in a mouse model of diabetic pregnancy.
Fine EL; Horal M; Chang TI; Fortin G; Loeken MR
Diabetes; 1999 Dec; 48(12):2454-62. PubMed ID: 10580436
[TBL] [Abstract][Full Text] [Related]
6. Insulin treatment fails to abolish the teratogenic potential of serum from diabetic rats.
Wentzel P; Eriksson UJ
Eur J Endocrinol; 1996 Apr; 134(4):459-66. PubMed ID: 8640298
[TBL] [Abstract][Full Text] [Related]
7. Diminished PGE2 content, enhanced PGE2 release and defects in 3H-PGE2 transport in embryos from overtly diabetic rats.
Jawerbaum A; Gonzalez ET; Sinner D; Pustovrh C; White V; Gimeno MA
Reprod Fertil Dev; 2000; 12(3-4):141-7. PubMed ID: 11302423
[TBL] [Abstract][Full Text] [Related]
8. Developmental damage, increased lipid peroxidation, diminished cyclooxygenase-2 gene expression, and lowered prostaglandin E2 levels in rat embryos exposed to a diabetic environment.
Wentzel P; Welsh N; Eriksson UJ
Diabetes; 1999 Apr; 48(4):813-20. PubMed ID: 10102698
[TBL] [Abstract][Full Text] [Related]
9. Interactive dysmorphogenic effects of toxaphene or toxaphene congeners and hyperglycemia on cultured whole rat embryos during organogenesis.
Calciu C; Kubow S; Chan HM
Toxicology; 2002 Jun; 175(1-3):153-65. PubMed ID: 12049844
[TBL] [Abstract][Full Text] [Related]
10. Effects of sera from Cohen, genetically determined diabetic rats, streptozotocin diabetic rats and sucrose fed rats on in vitro development of early somite rat embryos.
Ornoy A; Zusman I; Cohen AM; Shafrir E
Diabetes Res; 1986 Jan; 3(1):43-51. PubMed ID: 3514068
[TBL] [Abstract][Full Text] [Related]
11. In vitro development of rat embryos obtained from diabetic mothers.
Menegola E; Prati M; Broccia ML; Ricolfi R; Giavini E
Experientia; 1995 Apr; 51(4):394-7. PubMed ID: 7729505
[TBL] [Abstract][Full Text] [Related]
12. Hyperglycemia-induced embryonic dysmorphogenesis correlates with genomic DNA mutation frequency in vitro and in vivo.
Lee AT; Reis D; Eriksson UJ
Diabetes; 1999 Feb; 48(2):371-6. PubMed ID: 10334316
[TBL] [Abstract][Full Text] [Related]
13. Diabetic teratogenesis. In vitro evidence for a multifactorial etiology with little contribution from glucose per se.
Buchanan TA; Denno KM; Sipos GF; Sadler TW
Diabetes; 1994 May; 43(5):656-60. PubMed ID: 8168642
[TBL] [Abstract][Full Text] [Related]
14. Somatomedin inhibitors from diabetic rat serum alter growth and development of mouse embryos in culture.
Sadler TW; Phillips LS; Balkan W; Goldstein S
Diabetes; 1986 Aug; 35(8):861-5. PubMed ID: 3732629
[TBL] [Abstract][Full Text] [Related]
15. Evidence for multifactorial origin of diabetes-induced embryopathies.
Sadler TW; Hunter ES; Wynn RE; Phillips LS
Diabetes; 1989 Jan; 38(1):70-4. PubMed ID: 2909414
[TBL] [Abstract][Full Text] [Related]
16. Glycine decreases developmental damage induced by hyperglycaemia in mouse embryos.
Martínez-Galero E; Paniagua-Castro N; Pérez-Pastén R; Madrigal-Bujaidar E; Chamorro-Cevallos G
J Pharm Pharmacol; 2008 Jul; 60(7):895-900. PubMed ID: 18549676
[TBL] [Abstract][Full Text] [Related]
17. In vivo evidence for the existence of a threshold for hyperglycemia-induced major fetal malformations: relevance to the etiology of diabetic teratogenesis.
Torchinsky A; Toder V; Carp H; Orenstein H; Fein A
Early Pregnancy; 1997 Mar; 3(1):27-33. PubMed ID: 9265556
[TBL] [Abstract][Full Text] [Related]
18. Dietary myo-inositol therapy in hyperglycemia-induced embryopathy.
Khandelwal M; Reece EA; Wu YK; Borenstein M
Teratology; 1998 Feb; 57(2):79-84. PubMed ID: 9562680
[TBL] [Abstract][Full Text] [Related]
19. [Effect of hyperglycemia on rat embryos in vitro].
He WG
Zhonghua Fu Chan Ke Za Zhi; 1993 Oct; 28(10):586-8, 633-4. PubMed ID: 8112125
[TBL] [Abstract][Full Text] [Related]
20. Effects of glucose and serum from streptozotocin-diabetic and nondiabetic rats on the in vitro development of preimplantation mouse embryos.
Zusman I; Ornoy A; Yaffe P; Shafrir E
Isr J Med Sci; 1985 Apr; 21(4):359-65. PubMed ID: 3997500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
